PPAR gamma agonists (Kyoto Pharmaceutical Industries)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NamePPAR gamma agonists (Kyoto Pharmaceutical Industries)
Drug Alias NameKY-201KY-021
ClassificationSmall molecules
Mechanisms of ActionPeroxisome proliferator-activated receptor γ agonistsProtein-tyrosine phosphatase 1B inhibitors
TargetsProtein-tyrosine phosphatase 1BPeroxisome proliferator-activated receptor γ
Therapy Area/IndicationsDiabetes Mellitus
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesKyoto Pharmaceutical Industries Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKyoto Pharmaceutical Industries Ltd
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus

Other Information

ATC CodeN/A
Related LinksN/A